Center of Clinical Neuroscience

Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis

Link

https://doi.org/10.1186/s42466-022-00219-3

Tags

Multiple SkleroseMS Behandlung

Jahr

2022

Autoren

Regner-Nelke L, Pawlitzki M, Willison A, Rolfes L, Oezalp SH, Nelke C, Kölsche T, Korsen M, Grothe M, Groppa S, Luessi F, Engel S, Nelles G, Bonmann E, Roick H, Friedrich A, Knorn P, Landefeld H, Biro Z, Ernst M, Bayas A, Menacher M, Akgün K, Kleinschnitz C, Ruck T, Ziemssen T, Pul R, Meuth SG.

Verlag

Neurol Res Pract. 2022 Nov 7;4(1):55.

Zum Eintrag

Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study

Link

https://doi.org/10.1177/1756286421993999

Tags

Multiple SkleroseMS Behandlung

Jahr

2021

Autoren

Wundes A, Wray S, Gold R, Singer BA, Jasinska E, Ziemssen T, de Seze J, Repovic P, Chen H, Hanna J, Messer J, Miller C, Naismith RT.

Verlag

Ther Adv Neurol Disord. 2021 Mar 19;14:1756286421993999

Zum Eintrag

B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis

Link

https://doi.org/10.1212/nxi.0000000000000980

Tags

Multiple SkleroseMS Behandlung

Jahr

2021

Autoren

Tacke S, Braune S, Rovituso DM, Ziemssen T, Lehmann PV, Dikow H, Bergmann A, Kuerten S.

Verlag

Neurol Neuroimmunol Neuroinflamm. 2021 Mar 11;8(3):e980.

Zum Eintrag

Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial

Link

https://doi.org/10.1177/1756286420982134

Tags

Multiple SkleroseMS Behandlung

Jahr

2021

Autoren

Coles AJ, Arnold DL, Bass AD, Boster AL, Compston DAS, Fernández Ó, Havrdová EK, Nakamura K, Traboulsee A, Ziemssen T, Jacobs A, Margolin DH, Huang X, Daizadeh N, Chirieac MC, Selmaj KW.

Verlag

Ther Adv Neurol Disord. 2021 Apr 23;14:1756286420982134.

Zum Eintrag